
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
ASSAY ONLY TEMPLATE
A. 510(k) Number:
k141964
B. Purpose for Submission:
Clearance of new device-Addition of a new parameter - IPF# (10³/μL)
C. Measurand:
Assayed parameters: RBC(106/μL), HGB(g/dL), HCT(%), MCV(fL), MCH(pg),
MCHC(g/dL), PLT(103/μL), PLT-F(103/μL), RDW-SD(fL), RDW-CV(%), MPV(fL),
WBC(103/μL), NEUT(%), LYMPH (%), MONO(%), EO(%), BASO(%), IG(%),
NEUT#(103/μL), LYMPH#(103/μL), MONO# (103/μL), EO#(103/μL), BASO#(103/μL),
IG#(103/μL), IPF(%), RET#(106/μL), RET%, IRF%, RET-HE(pg), NRBC#(103/μL), and
NRBC% (/100 WBC), and IPF# (10³/μL).
D. Type of Test:
Quantitative
E. Applicant:
Streck Inc.
F. Proprietary and Established Names:
XN-CHECK™
G. Regulatory Information:
1. Regulation section:
21 CFR § 864.8625, Hematology quality control mixture
2. Classification:
Class II
3. Product code:
JPK, mixture, hematology quality control
1

--- Page 2 ---
4. Panel:
Hematology (81)
H. Intended Use:
1. Intended use(s):
XN CHECK is used for control and calibration verification of Sysmex XN (XN-10, XN-11,
XN-20, XN-21) analyzers. It is not, however, intended for actual calibration of these
analyzers.
Assayed parameters include: RBC(106/μL), HGB(g/dL), HCT(%), MCV(fL), MCH(pg),
MCHC(g/dL), PLT(103/μL), PLT-F(103/μL), RDW-SD(fL), RDW-CV(%), MPV(fL),
WBC(103/μL), NEUT(%), LYMPH (%), MONO(%), EO(%), BASO(%), IG(%),
NEUT#(103/μL), LYMPH#(103/μL), MONO# (103/μL), EO#(103/μL), BASO#(103/μL),
IG#(103/μL), IPF(%), RET#(106/μL), RET%, IRF%, IPF# (10³/μL), RET-HE(pg),
NRBC#(103/μL), and NRBC% (/100 WBC).
2. Indication(s) for use:
Same as intended use
3. Special conditions for use statement(s):
For prescription use only
4. Special instrument requirements:
Sysmex XN series (XN-10, XN-11, XN-20, XN-21) analyzers
I. Device Description:
XN CHECK™ is an in-vitro diagnostic product that contains the following: stabilized red
blood cell component(s), stabilized white blood cell component(s), stabilized platelet
component(s) and stabilized nucleated red blood cell component(s) in a preservative medium.
The control includes three levels (i.e., low, medium and high) which are packaged separately
in polypropylene plastic vials with screw caps containing 3mL. The vials will be packaged
in (4) welled vacuum formed clamshell container with the Instructions for Use (IFU) / assay
sheet. The product must be stored at 2 - 8°C.
J. Substantial Equivalence Information:
1. Predicate device name(s):
Streck XN CHECK™
2. Predicate 510(k) number(s):
2

--- Page 3 ---
k120742
3. Comparison with predicate:
Similarities
Item Device Predicate
Control Levels 3 levels same
Open-vial stability 7 days same
Closed-vial stability 84 days same
Storage conditions 2-8°C same
Reagents XN CHECK contains the following: same
stabilized red blood cell component(s),
stabilized white blood cell component(s),
stabilized platelet component(s), and
stabilized nucleated red blood cell
component(s) in a preservative medium.
Differences
Item Device Predicate
Intended Use XN CHECK is used for control and Only for Sysmex XN-
calibration verification of Sysmex XN 10 and XN-20 models
(XN-10, XN-20) analyzers. It is not,
however, intended for actual calibration of Assayed parameter
these analyzers. Assayed parameters IPF# (10³/ μL) not
include: RBC(106/μL), HGB(g/dL), available
HCT(%), MCV(fL), MCH(pg),
MCHC(g/dL), PLT(103/μL),
PLT-F(103/μL), RDW-SD(fL), RDW-
CV(%), MPV(fL), WBC(103/μL),
NEUT(%), LYMPH (%), MONO(%),
EO(%), BASO(%), IG(%),
NEUT#(103/μL), LYMPH#(103/μL),
MONO#(103/μL), EO#(103/μL),
BASO#(103/μL), IG#(103/μL), IPF(%),
RET#(106/μL), RET%, IRF%, RET-
HE(pg), NRBC#(103/μL), and NRBC%
(/100 WBC)
K. Standard/Guidance Document Referenced (if applicable):
CLSI H26-A2, Validation, Verification, and Quality Assurance of Automated Hematology
Analyzers, October 2010
CLSI EP5-A2 Methods, Evaluation of Precision Performance of Quantitative Measurement
Methods; Approved Guideline-Second Edition.
3

[Table 1 on page 3]
Similarities								
	Item			Device			Predicate	
Control Levels			3 levels			same		
Open-vial stability			7 days			same		
Closed-vial stability			84 days			same		
Storage conditions			2-8°C			same		
Reagents			XN CHECK contains the following:
stabilized red blood cell component(s),
stabilized white blood cell component(s),
stabilized platelet component(s), and
stabilized nucleated red blood cell
component(s) in a preservative medium.			same		

[Table 2 on page 3]
Differences								
	Item			Device			Predicate	
Intended Use			XN CHECK is used for control and
calibration verification of Sysmex XN
(XN-10, XN-20) analyzers. It is not,
however, intended for actual calibration of
these analyzers. Assayed parameters
include: RBC(106/μL), HGB(g/dL),
HCT(%), MCV(fL), MCH(pg),
MCHC(g/dL), PLT(103/μL),
PLT-F(103/μL), RDW-SD(fL), RDW-
CV(%), MPV(fL), WBC(103/μL),
NEUT(%), LYMPH (%), MONO(%),
EO(%), BASO(%), IG(%),
NEUT#(103/μL), LYMPH#(103/μL),
MONO#(103/μL), EO#(103/μL),
BASO#(103/μL), IG#(103/μL), IPF(%),
RET#(106/μL), RET%, IRF%, RET-
HE(pg), NRBC#(103/μL), and NRBC%
(/100 WBC)			Only for Sysmex XN-
10 and XN-20 models
Assayed parameter
IPF# (10³/ μL) not
available		

--- Page 4 ---
L. Test Principle:
Tri-level XN CHECK™ was designed to evaluate the accuracy and precision of the Sysmex
XN Series instruments. XN CHECK™ is for in-vitro diagnostic use only by laboratory
professionals.
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
Data were collected at 3 sites (two internal and at one external site) across 3 different
Sysmex XN-20 and XN-21 models analyzers, throughout the product dating claim using
3 separately manufactured lots numbers (3280, 3322, 3336) of XN-CHECK™ controls.
Studies were conducted for each lot at all three sites; all sites are within the U.S. Control
materials were shipped, stored, mixed, and handled in accordance with the instruction for
use. Acceptance criteria were based on compilation of the CV% for each measurand
across all models over multiple sites. Results collected across the three separately
manufactured lots of XN CHECK™ demonstrate consistent recovery across multiple
instruments, at multiple sites and were within the parameter specific assay assignment
ranges set forth for each measurand as shown in the cumulative summary by instrument
series in the tables below.
Sysmex XN-20 Model Level 1
Measurand (%CV)
WBC RBC HGB HCT MCV MCH MCHC PLT PLT- RDW RDW
F% -CV
Lot 3280 3.07 1.51 4.07 1.92 3.55 4.06 5.6 2.1 1.2 0.89 3.07
Lot 3322 1.78 3.75 1.46 4.25 1.68 4.06 4.1 6.1 2.2 1.19 1.06
Lot 3336 2.31 2.78 1.71 4.39 2.16 3.01 4.3 6.4 2.2 1.77 0.77
CV%
Acceptance 5.0 5.0 5.0 5.0 5.0 5.0 5.0 10.0 5.0 5.0 5.0
Criteria
Sysmex XN-20 Model Level 2
MeasuraLnedv e(l% 1 CV)
WBC RBC HGB HCT MMeaCsVu ranMd C(%H CVM) CHC PLT PLT- RDW RDW
WBC RBC HGB HCT MCV MCH MCHC PLT FP%L T- RDW -CRVD W
Lot 3280 1.81 3.23 0.78 3.93 1.80 3.75 4.16 4.0 5.F5 % 1.66 1.-1C4 V
LLoto t3 332228 0 1. 23 4. 01 0. 81 4. 39 1. 57 4. 54 4. 65 5. 5 3. 7 1. 36 1. 03
LLoto t3 333362 2 1. 6 2. 87 1. 11 4. 28 1. 94 3. 02 4. 27 3. 1 4. 0 1. 52 1. 09
CLVo%t 3336
ACccVe%pt ance 5.0 5.0 5.0 5.0 5.0 5.0 5.0 10.0 5.0 5.0 5.0
CArictecreipa tance 9.7 5.0 4.8 6.9 4.9 6.0 7.6 30.5 15.1 77.1
Criteria
Level1
Measurand(%CV)
WBC RBC HGB HCT MCV MCH MCHC PLT PLT- RDW RDW
F% -CV
Lot3280
Lot3322 4
Lot3336
CV%

[Table 1 on page 4]
Sysmex XN-20 Model Level 1											
Measurand (%CV)											
	WBC	RBC	HGB	HCT	MCV	MCH	MCHC	PLT	PLT-
F%	RDW	RDW
-CV
											
Lot 3280	3.07	1.51	4.07	1.92	3.55	4.06	5.6	2.1	1.2	0.89	3.07
Lot 3322	1.78	3.75	1.46	4.25	1.68	4.06	4.1	6.1	2.2	1.19	1.06
Lot 3336	2.31	2.78	1.71	4.39	2.16	3.01	4.3	6.4	2.2	1.77	0.77
CV%
Acceptance
Criteria	5.0	5.0			5.0	5.0			5.0	5.0	5.0
			5.0	5.0			5.0	10.0			
											

[Table 2 on page 4]
Sysmex XN-20 Model Level 2																								
	MeasuraLnedv e(l% 1 CV)																							
		WBC		RBC		HGB		HCT		MMeaCsVu ra		nMd C(%H C		VM) CHC		PLT		PLT-		RDW		RDW		
			WBC		RBC		HGB		HCT		MCV		MCH		MCHC		PLT		FP%L T-		RDW		-CRVD W	
	Lot 3280		1.81		3.23		0.78		3.93		1.80		3.75		4.16		4.0		5.F5 %		1.66		1.-1C4 V	
	LLoto t3 332228 0		1. 23		4. 01		0. 81		4. 39		1. 57		4. 54		4. 65		5. 5		3. 7		1. 36		1. 03	
	LLoto t3 333362 2		1. 6		2. 87		1. 11		4. 28		1. 94		3. 02		4. 27		3. 1		4. 0		1. 52		1. 09	
	CLVo%t 3336																							
	ACccVe%pt ance
CArictecreipa tance		5.0
9.7		5.0
5.0		5.0		5.0		5.0
4.9		5.0
6.0		5.0		10.0		5.0
15.1		5.0
77.1		5.0	
							4.8		6.9						7.6		30.5							
	Criteria																							
	Level1																							
	Measurand(%CV)																							
			WBC		RBC		HGB		HCT		MCV		MCH		MCHC		PLT		PLT-
F%		RDW		RDW
-CV	
	Lot3280																							
	Lot3322																						4	
	Lot3336																							
	CV%																							

--- Page 5 ---
Sysmex XN-20 Model Level 3
Measurand (%CV)
WBC RBC HGB HCT MCV MCH MCHC PLT PLT- RDW RDW-
F% CV
Lot 3280 1.30 2.58 0.81 3.13 1.67 2.99 3.21 3.7 2.7 1.42 1.22
Lot 3322 1.20 4.28 0.77 4.51 1.50 4.90 4.86 6.5 1.9 1.36 1.07
Lot 3336 0.92 2.55 0.98 3.81 1.73 2.61 3.71 3.3 1.7 1.30 1.69
CV%
Acceptance 5.0 5.0 5.0 5.0 5.0 5.0 5.0 10.0 5.0 5.0 5.0
Criteria
Sysmex XN-20 Model Level 1
Measurand (%CV)
MPV NEUT# LYMPH# MONO# EO# BASO# IG# NEUT% NEUT% LYMPH MONO
% %
Lot 3280 4.31 3.52 4.63 8.25 7.42 4.49 4.16 2.66 2.66 8.08 4.31
Lot 3322 5.48 3.41 5.04 10.8 7.58 3.46 3.74 2.83 2.83 10.52 5.48
Lot 3336 3.72 3.19 5.77 12.1 7.34 4.53 3.79 2.57 2.57 11.91 3.72
CV%
Acceptance 5.0 15.0 10.0 15.0 10.0 10.0 10.0 5.0 5.0 10.0 15.0
Criteria
Sysmex XN-20 Model Level 2
Measurand (%CV)
MPV NEUT# LYMPH# MONO# EO# BASO# IG# NEUT% NEUT% LYMPH MONO
% %
Lot 3280 2.18 2.62 3.99 8.89 7.7 3.04 3.19 1.96 1.96 8.35 2.18
Lot 3322 2.63 2.73 4.62 9.13 7.7 2.87 2.79 2.32 2.32 9.37 2.63
Lot 3336 1.95 2.95 4.20 9.86 7.9 3.14 3.59 2.24 2.24 9.52 1.95
CV%
Acceptance 5.0 5.0 10.0 15.0 10.0 5.0 5.0 5.0 5.0 10.0 15.0
Criteria
Sysmex XN-20 Model Level 3
Measurand (%CV)
MPV NEUT# LYMPH# MONO# EO# BASO# IG# NEUT% NEUT% LYMPH MONO
% %
Lot 3280 1.99 2.47 7.75 12.26 6.82 2.35 3.46 1.9 1.9 12.4 1.99
Lot 3322 2.23 2.43 6.37 11.51 %6.4 7 3.07 3.12 1.9 1.9 11.5 2.23
Lot 3336 1.96 2.18 5.69 11.43 %7.6 1 2.21 2.93 1.8 1.8 11.6 1.96
CV% %
Acceptance 5.0 5.0 10.0 15.0 10.0 5.0 5.00 5.0 5.0 10.0 15.0
Criteria
5

[Table 1 on page 5]
Sysmex XN-20 Model Level 3											
Measurand (%CV)											
	WBC	RBC	HGB	HCT	MCV	MCH	MCHC	PLT	PLT-
F%	RDW	RDW-
CV
											
Lot 3280	1.30	2.58	0.81	3.13	1.67	2.99	3.21	3.7	2.7	1.42	1.22
Lot 3322	1.20	4.28	0.77	4.51	1.50	4.90	4.86	6.5	1.9	1.36	1.07
Lot 3336	0.92	2.55	0.98	3.81	1.73	2.61	3.71	3.3	1.7	1.30	1.69
CV%
Acceptance
Criteria	5.0	5.0			5.0	5.0			5.0	5.0	5.0
			5.0	5.0			5.0	10.0			
											

[Table 2 on page 5]
Sysmex XN-20 Model Level 1											
Measurand (%CV)											
	MPV	NEUT#	LYMPH#	MONO#	EO#	BASO#	IG#	NEUT%	NEUT%	LYMPH
%	MONO
%
											
Lot 3280	4.31	3.52	4.63	8.25	7.42	4.49	4.16	2.66	2.66	8.08	4.31
Lot 3322	5.48	3.41	5.04	10.8	7.58	3.46	3.74	2.83	2.83	10.52	5.48
Lot 3336	3.72	3.19	5.77	12.1	7.34	4.53	3.79	2.57	2.57	11.91	3.72
CV%
Acceptance
Criteria	5.0	15.0			10.0	10.0			5.0	10.0	15.0
			10.0	15.0			10.0	5.0			
											

[Table 3 on page 5]
Sysmex XN-20 Model Level 2											
Measurand (%CV)											
	MPV	NEUT#	LYMPH#	MONO#	EO#	BASO#	IG#	NEUT%	NEUT%	LYMPH
%	MONO
%
											
Lot 3280	2.18	2.62	3.99	8.89	7.7	3.04	3.19	1.96	1.96	8.35	2.18
Lot 3322	2.63	2.73	4.62	9.13	7.7	2.87	2.79	2.32	2.32	9.37	2.63
Lot 3336	1.95	2.95	4.20	9.86	7.9	3.14	3.59	2.24	2.24	9.52	1.95
CV%
Acceptance
Criteria	5.0	5.0			10.0	5.0			5.0	10.0	15.0
			10.0	15.0			5.0	5.0			
											

[Table 4 on page 5]
Sysmex XN-20 Model Level 3											
Measurand (%CV)											
	MPV	NEUT#	LYMPH#	MONO#	EO#	BASO#	IG#	NEUT%	NEUT%	LYMPH
%	MONO
%
											
Lot 3280	1.99	2.47	7.75	12.26	6.82	2.35	3.46	1.9	1.9	12.4	1.99
Lot 3322	2.23	2.43	6.37	11.51	%6.4 7	3.07	3.12	1.9	1.9	11.5	2.23
Lot 3336	1.96	2.18	5.69	11.43	%7.6 1	2.21	2.93	1.8	1.8	11.6	1.96
CV%
Acceptance
Criteria	5.0	5.0			%
10.0	5.0			5.0	10.0	15.0
			10.0	15.0			5.00	5.0			
											

--- Page 6 ---
Sysmex XN-20 Model Level 1
Measurand (%CV)
EO% BASO% IG% NRBC# NRBC RET# RET% IRF RET-He IPF% IPF#
%
Lot 3280 7.22 3.62 3.37 10.44 10.11 9.08 6.91 11.00 1.84 2.94 3.74
Lot 3322 7.41 3.26 3.24 9.20 9.62 8.68 6.70 19.44 8.35 2.83 3.52
Lot 3336 7.02 3.71 3.46 8.38 8.61 6.28 5.49 16.37 5.15 2.19 3.03
CV%
Acceptance 10.0 5.0 5.0 15.0 15.0 10.0 10.0 20.0 5.0 5.0 10.0
Criteria
Sysmex XN-20 Model Level 2
Measurand (%CV)
EO% BASO% IG% NRBC# NRBC RET# RET% IRF RET-He IPF% IPF#
%
Lot 3280 7.33 2.56 2.79 5.68 5.86 5.38 4.10 9.62 1.47 3.88 8.09
Lot 3322 7.41 2.74 2.35 4.82 4.95 7.48 6.09 20.31 7.16 4.65 6.14
Lot 3336 7.50 2.64 2.98 6.10 6.37 5.31 4.81 13.75 4.34 3.34 4.12
CV%
Acceptance 10.0 5.0 5.0 5.0 5.0 10.0 10.0 20.0 5.0 5.0 10.0
Criteria
Sysmex XN-20 Model Level 3
Measurand (%CV)
EO% BASO% IG% NRBC# NRBC RET# RET% IRF RET-He IPF% IPF#
%
Lot 3280 6.8 2.4 3.1 4.22 3.99 9.39 9.46 11.27 1.81 4.91 6.14
Lot 3322 6.6 2.6 2.8 3.10 3.27 9.01 9.60 15.73 8.18 3.57 4.55
Lot 3336 7.7 2.1 2.8 3.12 3.28 7.88 8.10 13.51 5.91 2.92 3.01
CV%
Acceptance 10.0 5.0 5.0 5.0 5.0 10.0 10.0 15.0 5.0 10.0 10.0
Criteria
Sysmex XN-21 Model Level 1
Measurand (%CV)
WBC RBC HGB HCT MCV MCH MCHC PLT PLT- RDW RDW-
F% CV
Lot 3280 2.215 3.07 1.51 4.07 1.92 3.55 4.06 5.6 2.1 1.24 0.89
Lot 3322 1.776 3.74 1.46 4.25 1.68 4.06 4.14 6.1 2.2 1.19 1.06
Lot 3336 2.315 2.77 1.71 4.39 2.16 3.01 4.33 6.4 2.2 1.77 0.77
CV%
Acceptance 5.0 5.0 5.0 5.0 5.0 5.0 5.0 10.0 10.0 5.0 5.0
Criteria
6

[Table 1 on page 6]
Sysmex XN-20 Model Level 1											
Measurand (%CV)											
	EO%	BASO%	IG%	NRBC#	NRBC
%	RET#	RET%	IRF	RET-He	IPF%	IPF#
											
Lot 3280	7.22	3.62	3.37	10.44	10.11	9.08	6.91	11.00	1.84	2.94	3.74
Lot 3322	7.41	3.26	3.24	9.20	9.62	8.68	6.70	19.44	8.35	2.83	3.52
Lot 3336	7.02	3.71	3.46	8.38	8.61	6.28	5.49	16.37	5.15	2.19	3.03
CV%
Acceptance
Criteria	10.0	5.0			15.0	10.0			5.0	5.0	
			5.0	15.0			10.0	20.0			10.0
											

[Table 2 on page 6]
Sysmex XN-20 Model Level 2											
Measurand (%CV)											
	EO%	BASO%	IG%	NRBC#	NRBC
%	RET#	RET%	IRF	RET-He	IPF%	IPF#
											
Lot 3280	7.33	2.56	2.79	5.68	5.86	5.38	4.10	9.62	1.47	3.88	8.09
Lot 3322	7.41	2.74	2.35	4.82	4.95	7.48	6.09	20.31	7.16	4.65	6.14
Lot 3336	7.50	2.64	2.98	6.10	6.37	5.31	4.81	13.75	4.34	3.34	4.12
CV%
Acceptance
Criteria	10.0	5.0			5.0	10.0			5.0	5.0	
			5.0	5.0			10.0	20.0			10.0
											

[Table 3 on page 6]
Sysmex XN-20 Model Level 3											
Measurand (%CV)											
	EO%	BASO%	IG%	NRBC#	NRBC
%	RET#	RET%	IRF	RET-He	IPF%	IPF#
											
Lot 3280	6.8	2.4	3.1	4.22	3.99	9.39	9.46	11.27	1.81	4.91	6.14
Lot 3322	6.6	2.6	2.8	3.10	3.27	9.01	9.60	15.73	8.18	3.57	4.55
Lot 3336	7.7	2.1	2.8	3.12	3.28	7.88	8.10	13.51	5.91	2.92	3.01
CV%
Acceptance
Criteria	10.0	5.0			5.0	10.0			5.0	10.0	
			5.0	5.0			10.0	15.0			10.0
											

[Table 4 on page 6]
Sysmex XN-21 Model Level 1											
Measurand (%CV)											
	WBC	RBC	HGB	HCT	MCV	MCH	MCHC	PLT	PLT-
F%	RDW	RDW-
CV
											
Lot 3280	2.215	3.07	1.51	4.07	1.92	3.55	4.06	5.6	2.1	1.24	0.89
Lot 3322	1.776	3.74	1.46	4.25	1.68	4.06	4.14	6.1	2.2	1.19	1.06
Lot 3336	2.315	2.77	1.71	4.39	2.16	3.01	4.33	6.4	2.2	1.77	0.77
CV%
Acceptance
Criteria	5.0	5.0			5.0	5.0			10.0	5.0	5.0
			5.0	5.0			5.0	10.0			
											

--- Page 7 ---
Sysmex XN-21 Model Level 2
MeasurLaenvde (l %1 CV)
WBC RBC HGB HCT MMeaCsVu ranMd C(%H CVM) CHC PLT PLT- RDW RDW-
WBC RBC HGB HCT MCV MCH MCHC PLT FP%L T- RDW CRV DW
Lot 3280 1.80 3.23 0.78 3.93 1.80 3.75 4.16 4.0 5.F5 % 1.66 1.-1C4 V
LLoto t3 332228 0 1. 23 4. 00 0. 81 4. 39 1. 57 4. 54 4. 65 5. 5 3. 7 1. 36 1. 03
LLoto t3 333362 2 1. 67 2. 87 1. 11 4. 28 1. 94 3. 02 4. 27 3. 1 4. 0 1. 52 1. 09
CLVo%t 3336
ACccVe%pt ance 5.0 5.0 5.0 5.0 5.0 5.0 5.0 10.0 10.0 5.0 5.0
CArictecreipa tance 9.7 5.0 4.8 6.9 4.9 6.0 7.6 30.5 15.1 77.1
Criteria
Level 1
SysmeMx XeaNs-u2r1a nMdo (d%elC LVev) el 3
WBC RBC HGB HCMT eaMsuCraVn d M(%CCHV ) MCHC PLT PLT- RDW RDW
F% -CV
WBC RBC HGB HCT MCV MCH MCHC PLT PLT- RDW RDW-
Lot3280 F % C V
LLoot t3 3238202 1. 29 2. 58 0. 81 3. 13 1. 67 2. 99 3. 21 3. 7 2. 7 1. 42 1. 22
LLoot t3 3332326 .2 01 4. 28 0. 77 4. 51 1. 50 4. 90 4. 86 6. 5 1. 9 1. 36 1. 07
LCoVt 3%3 36 0 .92 2. 55 0. 98 3. 81 1. 73 2. 61 3. 71 3. 3 1. 7 1. 30 1. 69
CAVc%ce ptance 9.7 5.0 4.8 6.9 4.9 6.0 7.6 30.5 15.1 77.1
ACcrcieteprtiaan ce 5.0 5.0 5.0 5.0 5.0 5.0 5.0 10.0 10.0 5.0 5.0
Criteria
Sysmex XN-21 Model Level 1
Measurand (%CV)
MPV NEUT# LYMPH# MONO# EO# BASO# IG# NEUT% NEUT% LYMPH MONO
% %
Lot 3280 4.31 3.523 4.63 8.25 7.42 4.49 4.15 2.66 2.66 8.08 4.31
Lot 3322 3.41 5.04 10.77 7.58 3.46 3.73 2.83 4.82 4.82 3.41 5.04
Lot 3336 3.19 5.77 12.14 7.34 4.53 3.79 2.57 5.08 5.08 3.19 5.77
CV% %
Acceptance 5.0 5.0 10.0 15.0 10.0 5.0 5.0 5.0 5.0 10.0 15.0
Criteria
Sysmex XN-21 Model Level 2
Measurand (%CV)
MPV NEUT# LYMPH# MONO# EO# BASO# IG# NEUT% NEUT% LYMPH MONO
% %
Lot 3280 2.18 2.62 4.00 8.88 7.78 3.03 3.19 1.96 1.96 8.35 2.18
Lot 3322 2.63 2.73 4.63 9.133 7%.6 5 2.87 2.79 2.32 2.32 9.37 2.63
Lot 3336 1.95 2.95 4.20 9.85 7.82 3.14 3.58 2.24 2.24 9.52 1.95
CV%
Acceptance 5.0 5.0 10.0 15.0 10.0 5.0 5.0 5.0 5.0 10.0 15.0
Criteria
7

[Table 1 on page 7]
Sysmex XN-21 Model Level 2																								
	MeasurLaenvde (l %1 CV)																							
		WBC		RBC		HGB		HCT		MMeaCsVu ra		nMd C(%H C		VM) CHC		PLT		PLT-		RDW		RDW-		
			WBC		RBC		HGB		HCT		MCV		MCH		MCHC		PLT		FP%L T-		RDW		CRV DW	
	Lot 3280		1.80		3.23		0.78		3.93		1.80		3.75		4.16		4.0		5.F5 %		1.66		1.-1C4 V	
	LLoto t3 332228 0		1. 23		4. 00		0. 81		4. 39		1. 57		4. 54		4. 65		5. 5		3. 7		1. 36		1. 03	
	LLoto t3 333362 2		1. 67		2. 87		1. 11		4. 28		1. 94		3. 02		4. 27		3. 1		4. 0		1. 52		1. 09	
	CLVo%t 3336																							
	ACccVe%pt ance
CArictecreipa tance		5.0
9.7		5.0
5.0		5.0		5.0		5.0
4.9		5.0
6.0		5.0		10.0		10.0
15.1		5.0
77.1		5.0	
							4.8		6.9						7.6		30.5							
	Criteria																							
	Level 1																							
	SysmeMx XeaNs-u2r1a nMdo (d%elC LVev) el 3																							
			WBC		RBC		HGB		HCMT e		aMsuCraVn		d M(%CCHV		) MCHC		PLT		PLT-		RDW		RDW	
			WBC		RBC		HGB		HCT		MCV		MCH		MCHC		PLT		F%
PLT-		RDW		-CV
RDW-	
	Lot3280																		F%				CV	
	LLoot t3 3238202		1. 29		2. 58		0. 81		3. 13		1. 67		2. 99		3. 21		3. 7		2. 7		1. 42		1. 22	
	LLoot t3 3332326		.2 01		4. 28		0. 77		4. 51		1. 50		4. 90		4. 86		6. 5		1. 9		1. 36		1. 07	
	LCoVt 3%3 36		0 .92		2. 55		0. 98		3. 81		1. 73		2. 61		3. 71		3. 3		1. 7		1. 30		1. 69	
CAVc%ce ptance
ACcrcieteprtiaan ce
Criteria	CAVc%ce ptance
ACcrcieteprtiaan ce		9.7
5.0		5.0
5.0		4.8		6.9		4.9
5.0		6.0
5.0		7.6		30.5		15.1
10.0		77.1
5.0		5.0	
							5.0		5.0						5.0		10.0							
																								

[Table 2 on page 7]
Sysmex XN-21 Model Level 1											
Measurand (%CV)											
	MPV	NEUT#	LYMPH#	MONO#	EO#	BASO#	IG#	NEUT%	NEUT%	LYMPH
%	MONO
%
											
Lot 3280	4.31	3.523	4.63	8.25	7.42	4.49	4.15	2.66	2.66	8.08	4.31
Lot 3322	3.41	5.04	10.77	7.58	3.46	3.73	2.83	4.82	4.82	3.41	5.04
Lot 3336	3.19	5.77	12.14	7.34	4.53	3.79	2.57	5.08	5.08	3.19	5.77
CV%
Acceptance
Criteria	5.0	5.0			%
10.0	5.0			5.0	10.0	15.0
			10.0	15.0			5.0	5.0			
											

[Table 3 on page 7]
Sysmex XN-21 Model Level 2											
Measurand (%CV)											
	MPV	NEUT#	LYMPH#	MONO#	EO#	BASO#	IG#	NEUT%	NEUT%	LYMPH
%	MONO
%
											
Lot 3280	2.18	2.62	4.00	8.88	7.78	3.03	3.19	1.96	1.96	8.35	2.18
Lot 3322	2.63	2.73	4.63	9.133	7%.6 5	2.87	2.79	2.32	2.32	9.37	2.63
Lot 3336	1.95	2.95	4.20	9.85	7.82	3.14	3.58	2.24	2.24	9.52	1.95
CV%
Acceptance
Criteria	5.0	5.0			10.0	5.0			5.0	10.0	15.0
			10.0	15.0			5.0	5.0			
											

--- Page 8 ---
Sysmex XN-21 Model Level 3
Measurand (%CV)
MPV NEUT# LYMPH# MONO# EO# BASO# IG# NEUT% NEUT% LYMPH MONO
% %
Lot 3280 2.0 2.48 7.76 12.2 6.8 2.35 3.46 1.91 1.91 12.4 1.99
Lot 3322
2.2 2.43 6.37 11.5 6.5 3.07 3.12 1.92 1.92 11.59 2.23
Lot 3336 2.0 2.18 5.69 11.4 7.6 2.21 2.93 1.89 1.89 11.67 1.96
CV%
Acceptance 5.0 5.0 10.0 15.0 10.0 5.0 5.0 5.0 5.0 10.0 15.0
Criteria
Sysmex XN-21 Model Level 1
Measurand (%CV)
EO% BASO% IG% NRBC# NRBC RET# RET% IRF RET-He IPF% IPF#
%
Lot 3280 7.22 3.62 3.37 10.4 10.11 9.078 6.917 11.00 1.84 2.94 3.74
Lot 3322 7.41 3.26 3.24 9.20 9.62 8.684 6.70 19.44 8.35 2.83 3.52
Lot 3336 7.02 3.71 3.46 8.38 8.61 6.28 5.49 16.37 5.15 2.19 3.03
CV%
Acceptance 10.0 5.0 5.0 15.0 15.0 10.0 10.0 20.0 10.0 5.0 5.0
Criteria
Sysmex XN-21 Model Level 2
Measurand (%CV)
EO% BASO% IG% NRBC# NRBC RET# RET% IRF RET-He IPF% IPF#
%
Lot 3280 7.3 2.6 2.8 5.7 5.86 5.38 4.1 9.6 1.47 3.88 8.09
Lot 3322 7.4 2.7 2.4 4.8 4.95 7.48 6.1 20.3 7.16 4.65 6.14
Lot 3336 7.5 2.6 3.0 6.1 6.37 5.32 4.8 13.8 4.34 3.34 4.12
CV%
Acceptance 10.0 5.0 5.0 15.0 15.0 10.0 10.0 20.0 10.0 5.0 5.0
Criteria
Sysmex XN-21 Model Level 3
Measurand (%CV)
EO% BASO% IG% NRBC# NRBC RET# RET% IRF RET-He IPF% IPF#
%
Lot 3280 6.8 2.4 3.1 4.2 4.0 9.4 9.5 11.3 1.9 4.9 6.1
Lot 3322 6.6 2.6 2.8 3.1 3.3 9.0 9.6 15.8 8.2 3.6 4. 6
Lot 3336 7.7 2.1 2.8 3.1 3.3 7.9 8.1 13.5 6.0 2.9 3.0
CV%
Acceptance 10.0 5.0 5.0 15.0 15.0 10.0 10.0 20.0 10.0 5.0 5.0
Criteria
8

[Table 1 on page 8]
Sysmex XN-21 Model Level 3											
Measurand (%CV)											
	MPV	NEUT#	LYMPH#	MONO#	EO#	BASO#	IG#	NEUT%	NEUT%	LYMPH
%	MONO
%
											
Lot 3280	2.0	2.48	7.76	12.2	6.8	2.35	3.46	1.91	1.91	12.4	1.99
Lot 3322	2.2	2.43			6.5	3.07			1.92	11.59	2.23
			6.37	11.5			3.12	1.92			
											
Lot 3336	2.0	2.18	5.69	11.4	7.6	2.21	2.93	1.89	1.89	11.67	1.96
CV%
Acceptance
Criteria	5.0	5.0			10.0	5.0			5.0	10.0	15.0
			10.0	15.0			5.0	5.0			
											

[Table 2 on page 8]
Sysmex XN-21 Model Level 1											
Measurand (%CV)											
	EO%	BASO%	IG%	NRBC#	NRBC
%	RET#	RET%	IRF	RET-He	IPF%	IPF#
											
Lot 3280	7.22	3.62	3.37	10.4	10.11	9.078	6.917	11.00	1.84	2.94	3.74
Lot 3322	7.41	3.26	3.24	9.20	9.62	8.684	6.70	19.44	8.35	2.83	3.52
Lot 3336	7.02	3.71	3.46	8.38	8.61	6.28	5.49	16.37	5.15	2.19	3.03
CV%
Acceptance
Criteria	10.0	5.0			15.0	10.0			10.0	5.0	
			5.0	15.0			10.0	20.0			5.0
											

[Table 3 on page 8]
Sysmex XN-21 Model Level 2											
Measurand (%CV)											
	EO%	BASO%	IG%	NRBC#	NRBC
%	RET#	RET%	IRF	RET-He	IPF%	IPF#
											
Lot 3280	7.3	2.6	2.8	5.7	5.86	5.38	4.1	9.6	1.47	3.88	8.09
Lot 3322	7.4	2.7	2.4	4.8	4.95	7.48	6.1	20.3	7.16	4.65	6.14
Lot 3336	7.5	2.6	3.0	6.1	6.37	5.32	4.8	13.8	4.34	3.34	4.12
CV%
Acceptance
Criteria	10.0	5.0			15.0	10.0			10.0	5.0	
			5.0	15.0			10.0	20.0			5.0
											

[Table 4 on page 8]
Sysmex XN-21 Model Level 3											
Measurand (%CV)											
	EO%	BASO%	IG%	NRBC#	NRBC
%	RET#	RET%	IRF	RET-He	IPF%	IPF#
											
Lot 3280	6.8	2.4	3.1	4.2	4.0	9.4	9.5	11.3	1.9	4.9	6.1
Lot 3322	6.6	2.6	2.8	3.1	3.3	9.0	9.6	15.8	8.2	3.6	4. 6
Lot 3336	7.7	2.1	2.8	3.1	3.3	7.9	8.1	13.5	6.0	2.9	3.0
CV%
Acceptance
Criteria	10.0	5.0	5.0	15.0	15.0	10.0			10.0	5.0	
							10.0	20.0			5.0
											

--- Page 9 ---
b. Linearity/assay reportable range:
Not applicable
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Value assignments:
Value assignment was performed on three Sysmex XN-10 and three Sysmex XN-
20 analyzers using two vials of each control level tested a minimum of five times
per vial. A 10-run reproducibility study was conducted at the beginning and end of
each product dating claim for the tri-level control on each lot (n=60 per level).
Data collected from three lots (3280, 3822, and 3336) from all three sites were used
to calculate the mean, standard deviation (SD), and coefficient of variation (CV) for
each parameter analyzed. The database allows computation and comparison of data
that are used in the assay value assignment process as defined by controlled
documents. The expected range values assigned to the measurands were based on
the ± 3.0 SD of the total-run data and established product performance
characteristics. Total-run encompasses the values generated over multiple
combined data sets compiled for all three lots of control.
Reagent Stability
Acceptance criteria for open and closed-vial stability was based on a compilation of
the CV% for each measurand over data collected across four different Sysmex XN-20
and XN-21 analyzers, at 3 sites, throughout the stability study claim, with three
separately manufactured lots of XN CHECK™.
Open-vial stability: A 7 day open-vial stability claim was validated at the end of the
84-day product expiration claim. Two vials of each control level from each of the
three reference lots were analyzed on XN-20 and XN-21 series analyzers in duplicate
over a period of eight days. A minimum of four data points were collected at each
testing event performed by one operator internally at Streck. On a daily basis, vials
were removed from storage and mixed in accordance with the instructions for use to
simulate daily customer usage/handling.
Closed-vial stability: Three separately manufactured lots of XN CHECK™ lots were
set up to validate closed-vial stability performance throughout the 84-day stability
study at refrigerated temperatures (2-8C). Two vials of control per level from each
reference lot were used at each testing interval for this study. Data was collected
internally with one operator on one instrument at each testing event. A minimum of
four data points were collected at each testing event for 85 days to cover the 84-day
closed-vial stability claim. Data were collected and analyzed using CLSI EP5-A2
methods on the XN-20 andXN-21 series analyzers.
All reported CV% values for open and closed-vial reagent stability study were within
the acceptable threshold values as shown in the tables for the acceptance criteria
above in section M.1 (a).
9

--- Page 10 ---
d. Detection limit:
Not applicable
e. Analytical specificity:
Not applicable
f. Assay cut-off:
Not applicable
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable
b. Matrix comparison:
Not applicable
3. Clinical studies:
a. Clinical Sensitivity:
Not applicable
b. Clinical specificity:
Not applicable
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable
4. Clinical cut-off:
Not applicable
5. Expected values/Reference range:
The end-user is instructed to refer to the product assay sheet accompanying the instructions
for use.
10

--- Page 11 ---
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
11